Allergy immunotherapy market accounted for a market value of US$ 1,953.1 Mn in 2020 and projected to grow at a CAGR of 10.1% during the forecast period from 2025 to 2033. Allergy immunotherapy helps to prevent or minimize the allergic reactions and provide log-term benefit to patients. This therapy helps to increase immunological tolerance and changes the course of disease due to which demand for immunotherapy is increasing globally.
Cutaneous mastocytosis treatment market accounted for a market value of US$ 230.27 Mn in 2021 and projected to grow at a CAGR of 5.6% during the forecast period from 2025 to 2033. Cutaneous mastocytosis is a rare disease in which uncontrolled production of mast cells leads to skin complications such as lesions, blisters, and rashes with aggravated itching.
The Intravitreal injectables market will be showcasing stable growth at a compound annual growth rate (CAGR) of 4.8% during the forecast period from 2025 to 2033. According to the statistics provided by World Health Organization (WHO) approximately 1.3 billion people throughout the globe are suffering with some form of blindness caused majorly due to macular degeneration, diabetic retinopathy, ocular vein occlusions, endophthalmitis and retinitis. Intravitreal injections are being preferred over other treatment options for treating disease associated visual impairment.
Bronchitis treatment market accounted for a market value of US$ 3,509.7 Mn in 2021 and is projected to grow at a CAGR of 4.9% during the forecast period from 2025 to 2033. Bronchitis treatment market is growing gradually throughout the forecast period due to strong product pipeline equipped with target-specific drugs, and rising prevalence & awareness related to the treatment & diagnosis of bronchitis. The major cause of bronchitis is frequent cigarette smoking coupled with exposure to air pollutants.
Hemorrhoids are characterized by swelling and inflammation of veins in the anal canal and cause irritation, pain and itching to the patients. At present, several sufferers seek relief with an assortment of products such as home remedies, topical ointments of varying strengths and compositions. Direct application products offer temporary relief and have to be used for a limited period.
Veterinary pain management market accounted for a market projected to grow at a CAGR of 7.9% during the forecast period from 2025 to 2033. Rising humanization of animals due to developing trend of nuclear family, continuous development in the research & development activities related to the veterinary pain management, and scheduled diagnostics sessions for livestock to maintain the quality of the meat, milk and other products. Improper feeding and unorganized health management of pets & livestock animals leads to obesity and finally leading to joint pain and other disorders. In addition to that, pet and livestock owners are also being counselled & trained by non-government organizations or veterinary doctors to manage health of animals.
The soy lecithin market expected to reach US$ 1.51 Bn in 2033 growing at a CAGR of 5.8% during the forecast period from 2025 to 2033. Soy lecithin is a food additive sourced from soy. It acts as an emulsifier or lubricant when added to food. It is one of the most widely used food additive in the market.
Anemia treatment drugs market accounted for a market value of US$ 38,345.2 Mn in 2021 and projected to grow at a CAGR of 16.4% during the forecast period from 2025 to 2033. An abnormal decrease in the level of red blood cells, irregular red blood cell morphology, or inadequate concentration of haemoglobin in the blood results in anemia.
Microplate instrumentation are important devices used in cell culture and other research. Initially used only in research settings, these equipment have witnessed adoption in disease diagnostics, and therefore in diagnostic laboratories and hospitals. Microplate instrumentation and supplies are laboratory equipment used for understanding the discovery and development of drugs, and assessing the biological, chemical and physical reactions in any research. Microplate systems and supplies are therefore imperative in testing processes such as gene expression, toxicity, protein quantification, and biological reactions.
The diaphragm pumps market is set to grow from US$ 4,177.5 Mn to US$ 6,706.2 Mn at a compounded annual growth rate of 5.4% from 2018 to 2026. Diaphragm pumps are employed for pumping fluids by reciprocating the motion of diaphragm. Rampant growth in industrial sector and increasing production in food and beverage industry drive the diaphragm pumps market growth.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.